PCG vs STRO
PG&E Corp (PCG) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
PCG does not have a complete income-statement cache yet.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PCG currently screens at market cap $37.68B and trailing P/E 13.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PCG and STRO stock pages for the full models.
Not investment advice.